Fig. 2: The effect of i.v. iron on the composite endpoint of total (first and recurrent) HF hospitalizations and cardiovascular mortality over the complete length of follow-up (PB = 0.022, I2 = 46%). | Nature Medicine

Fig. 2: The effect of i.v. iron on the composite endpoint of total (first and recurrent) HF hospitalizations and cardiovascular mortality over the complete length of follow-up (PB = 0.022, I2 = 46%).

From: Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency

Fig. 2

The Forest plot illustrates the impact of i.v. iron on the composite endpoint of total (first and recurrent) HF hospitalizations and cardiovascular mortality over the complete length of follow-up using a Bayesian random-effects meta-analysis. The data are presented as RRs with 95% CIs. Sensitivity analyses were conducted by omitting the FAIR-HF and CONFIRM-HF studies, through the application of alternative HN priors and using the KnHa approach to random-effects meta-analysis. The blue color indicates analysis using six trials and the red color analysis using four trials.

Back to article page